Prognostic Impact of Activating Mutations of the NRAS/KRAS Genes in Patients with Primary and Post-Essential Thrombocythemia (ET)/Polycythemia Vera (PV) Myelofibrosis (MF)

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共4页
• 作者

  Santos Fabio P. S.; Getta Bartlomiej; Masarova Lucia; Famulare Christopher; Schulman Jessica; Puga Renato D.; Alves Paiva Raquel de Melo; Hamerschlak Nelson; Kantarjian Hagop M.; Levine Ross L.; Campregher Paulo Vidal; Rampal Raajit K.; Verstovsek Srdan;

  展开▼
• 作者单位

  Hosp Israelita Albert Einstein Sao Paulo SP Brazil;

  NSW Hlth Westmead NSW Australia;

  Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

  Mem Sloan Kettering Canc Ctr Ctr Hematol Malignancies 1275 York Ave New York NY 10021 USA;

  Mem Sloan Kettering Canc Ctr Ctr Hematol Malignancies 1275 York Ave New York NY 10021 USA;

  Hosp Israelita Albert Einstein Sao Paulo SP Brazil;

  Hosp Israelita Albert Einstein Sao Paulo SP Brazil;

  Hosp Israelita Albert Einstein Sao Paulo SP Brazil;

  Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

  Mem Sloan Kettering Canc Ctr Ctr Hematol Malignancies 1275 York Ave New York NY 10021 USA;

  Hosp Israelita Albert Einstein Sao Paulo SP Brazil;

  Mem Sloan Kettering Canc Ctr Dept Med Leukemia Serv 1275 York Ave New York NY 10021 USA;

  Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词